Rakhi Kumar - Apr 20, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Chief Accounting Officer
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar
Stock symbol: ROIV
Transactions as of: Apr 20, 2023
Transactions value $: -$13,807
Form type: 4
Date filed: 4/24/2023, 09:28 PM
Previous filing: Mar 27, 2023
Next filing: Apr 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Award	$0	+66.7K	+49.42%	$0.00	202K	Apr 20, 2023	Direct	F1, F2
transaction	ROIV	Common Shares	Tax liability	-$13.8K	-1.57K	-0.78%	$8.80	200K	Apr 20, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ROIV	Stock Option (Right to Buy)	Award	$0	+286K		$0.00	286K	Apr 20, 2023	Common Shares	286K	$8.80	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects an award of 66,710 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2023. 1/4 of the RSUs service-vest twelve (12) months after the vesting commencement date; 1/16 of the RSUs service-vest fourteen (14) months after the vesting commencement date; and the balance of the RSUs service-vest in a series of eleven (11) successive equal quarterly installments measured from the date fourteen (14) months after the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date.
F2	Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.
F3	Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
F4	Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2023. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.